The Effect of Wnt/Beta-Catenin Signaling Inhibition on Oral Squamous Cell Carcinoma
ISEF · 2017 Biomedical and Health Sciences
Overview
Oral Squamous Cell Carcinoma (OSCC) is a cancer of the mouth epithelium with an annual incidence rate in the US of nearly 48,000 cases annually and a 5-year survival rate of only 65%. Cancer stem cells (CSCs) are believed to be responsible for progression of OSCC, possessing stem-cell qualities including pluripotency that drive tumor development and chemotherapy resistance. Within cancerous cells is a pathway called the Wnt/ß-catenin signaling pathway, known to play a pivotal role in OSCC and CSC survival. This pathway causes the degradation of cellular junctions and upregulation of cancer-driving genes through the binding to and activation of CREB binding protein (CBP), a transcriptional coactivator that drives tumor progression. One of the genes up-regulated by this pathway, DPAGT1, drives N-glycosylation of the cellular adhesion protein E-cadherin, thus facilitating tumor growth through epithelial-mesenchymal transition (EMT). This study aimed to inhibit CBP/Beta-catenin interaction through treatment with ICG-001, a Wnt pathway inhibitor. Western blot and tissue imaging revealed that in ICG-001-treated tumors, E-cadherin and Beta-catenin localized at cell membranes, while levels of EGFR, CTHRC1, GPT, and vimentin (all involved in EMT) were reduced. These results suggest that ICG-001 helps preserve adhesion proteins essential for maintenance of cell adherens junctions and prevent of cell proliferation. Because of the significance of Wnt signaling in CSC maintenance, ICG-001 may hold particular promise in preventing tumor growth and metastasis. Though further research is needed to determine optimal dosage and elucidate the full in vivo effects of ICG-001, it offers promising results in treating OSCC.
Awards (1)
- ADA Foundation: Second Award of $1,000 $1,000
Competition history
- ISEF 2017
Resources
Related projects
ISEF · 2017
Role of Wnt Self-Renewal Pathway in Regulating Tumor Initiating Cells in Breast Cancer
ISEF · 2023
Characterizing Differences in Growth and Invasion Between Epithelial and Mesenchymal Cell Lines in Oral Cavity Squamous Cell Carcinoma
ISEF · 2024
Synergistic Solutions Prove Promising in the Fight Against Squamous Cell Carcinoma Cancer
ISEF · 2015
Characterization of A Novel Groundbreaking Radioresistance Pathway in the Endometrial Cancer Stem Cell Niche: The Interplay of WNT, Cyclooxygenase-2 (COX-2), and Hypoxia Inducible Factor-1a (HIF-1a)
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair